Neurology Advisor

Insufficient Evidence for Essential Tremor Medical Therapies

Pharmacologic options for essential tremor lack sufficient evidence for tremor reduction in trials with longer follow-up durations.
MassDevice

Encora wins FDA clearance for wearable device for essential tremor

Encora Therapeutics announced today that it has received FDA 510(k) clearance for its Encora X1 wrist-worn device.
The Gazette

Groundbreaking Study Demonstrates Cala TAPS™ Therapy Reduces Hand Tremor in Essential Tremor Patients by Directly Modulating Brain Activity

SAN MATEO, Calif. and HONOLULU, Oct. 6, 2025 /PRNewswire/ — Cala ®, the bioelectronic medicine leader, announced today the publication of a groundbreaking study in the journal Brain Stimulation ...
Los Angeles Times

Essential Tremor Management: From Pharmacotherapy to Surgery and More

Propranolol and Primidone demonstrate efficacy in up to 70% of patients as first-line agents. MR-Guided Focused Ultrasound (MRgFUS) results in approximately 56% tremor reduction at 4 years. Deep Brain ...